微创与胸骨正中切开二尖瓣手术:启动微创项目时的短期结局比较
单中心回顾性研究纳入2012年1月至2019年5月605例二尖瓣手术患者(胸骨切开294例,微创311例),倾向性评分匹配后251对。微创组体外循环时间更长但主动脉阻断时间更短,再手术止血率、输血需求和住院时间更低,30天死亡率两组均低且无差异。
要点
- 微创二尖瓣手术再手术止血率2.4% vs 7.2%,输血需求19.1% vs 30.7%,均低于胸骨切开组
- 微创组住院时间5.0±2.7天,短于胸骨切开组7.2±4.6天
- 两组30天死亡率低(0.4% vs 0.8%),差异无统计学意义
核心结论
- 微创二尖瓣手术的短期结局与胸骨正中切开手术相当,启动微创项目未增加不良事件风险。
研究设计与样本
- 单中心回顾性研究,纳入2012年1月至2019年5月605例二尖瓣手术患者,其中胸骨切开294例、微创311例,倾向性评分匹配后251对。
主要发现
- 匹配分析中微创组体外循环时间更长(149±52 vs 133±57 min;P=0.001),主动脉阻断时间更短(97±36 vs 105±40 min;P=0.03)。
- 微创组再手术止血率更低(2.4% vs 7.2%;P=0.012),输血需求更低(19.1% vs 30.7%;P=0.003),住院时间更短(5.0±2.7 vs 7.2±4.6天;P<0.001)。
- 30天死亡率两组均低(0.4% vs 0.8%;P=0.56)。
临床怎么用
- 在有限数量外科医生和明确机构选择策略下启动微创二尖瓣项目,短期结局与胸骨切开相当,可考虑推广。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: An increasing number of mitral valve operations are performed using minimally invasive procedures. The initiation of a minimally invasive mitral valve surgery programme constitutes a unique opportunity to study outcome differences in patients with similar characteristics operated on through a sternotomy versus a minimally invasive procedure. The goal of this study was to compare short-term outcomes of patients undergoing mitral valve surgery before versus those having surgery after the introduction of a minimally invasive programme. METHODS: The single-centre study included mitral valve procedures performed through a sternotomy or with a minimally invasive approach between January 2012 and May 2019. Propensity score matching was performed to reduce selection bias. RESULTS: A total of 605 patients (294 sternotomy, 311 minimally invasive) who underwent mitral valve surgery were included in the analysis. Propensity score matching resulted in 251 matched pairs. In the propensity score-matched analysis, minimally invasive procedures had longer extracorporeal circulation duration (149 ± 52 vs 133 ± 57 min; P = 0.001) but shorter aortic occlusion duration (97 ± 36 vs 105 ± 40 min, P = 0.03). Minimally invasive procedures were associated with a lower incidence of reoperation for bleeding (2.4% vs 7.2%; P = 0.012), lower need for transfusion (19.1% vs 30.7%; P = 0.003) and shorter in-hospital stay (5.0 ± 2.7 vs 7.2 ± 4.6 days; P < 0.001). The 30-day mortality was low in both groups (0.4% vs 0.8%; P = 0.56). CONCLUSIONS: Minimally invasive mitral valve surgery was associated with short-term outcomes comparable to those with procedures performed through a sternotomy. Initiating a minimally invasive mitral valve programme with a limited number of surgeons and a well-executed institutional selection strategy did not confer an increased risk for adverse events.
引用
- Kastengren M, Svenarud P, Källner G, et al. Minimally invasive versus sternotomy mitral valve surgery when initiating a minimally invasive programme. Eur J Cardiothorac Surg. 2020. PMID: 32920639. doi:10.1093/ejcts/ezaa232
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。